The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mcmanus John L since 2005.
The trader's CIK number is 1193923.
At the time of the last reporting, Mcmanus John L was the President and CEO of Aeolus Pharmaceuticals, Inc.. (stock ticker symbol AOLS).
Also see all insider trading activities at Aeolus Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | AOLS | 10,000 | $3,500 | 0 | $0 | 0 | $0 |
| 2011 | AOLS | 40,300 | $20,748 | 0 | $0 | 0 | $0 |
| 2010 | AOLS | 10,000 | $4,000 | 0 | $0 | 0 | $0 |
| 2008 | AOLS | 18,000 | $7,020 | 18,000 | $7,830 | 0 | $0 |
| 2007 | AOLS | 5,000 | $2,750 | 0 | $0 | 0 | $0 |
| 2006 | AOLS | 7,000 | $5,875 | 0 | $0 | 0 | $0 |
| 2005 | AOLS | 18,000 | $17,517 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-03-06 | AOLS | Buy | 10,000 | .35 | 3,500 |
| 2011-05-24 | AOLS | Buy | 10,300 | .46 | 4,738 |
| 2011-05-18 | AOLS | Buy | 20,000 | .43 | 8,600 |
| 2011-03-15 | AOLS | Buy | 10,000 | .74 | 7,410 |
| 2010-04-15 | AOLS | Buy | 10,000 | .40 | 4,000 |
| 2008-10-01 | AOLS | Buy | 18,000 | .39 | 7,020 |
| 2008-10-01 | AOLS | Sale | 18,000 | .43 | 7,830 |
| 2007-07-30 | AOLS | Buy | 5,000 | .55 | 2,750 |
| 2006-07-19 | AOLS | Buy | 1,000 | .75 | 750 |
| 2006-03-21 | AOLS | Buy | 5,000 | .83 | 4,175 |
| 2005-12-30 | AOLS | Buy | 1,000 | .95 | 950 |
| 2005-09-22 | AOLS | Buy | 2,500 | 1.08 | 2,712 |
| 2005-08-23 | AOLS | Buy | 500 | .91 | 455 |
| 2005-08-10 | AOLS | Buy | 4,000 | .97 | 3,880 |
| 2005-07-21 | AOLS | Buy | 1,000 | .97 | 970 |
| 2005-07-08 | AOLS | Buy | 10,000 | .95 | 9,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcmanus John L (President and CEO of Aeolus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.